NONALCOHOLIC STEATOHEPATITIS
Clinical trials for NONALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NONALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in shrinking fatty liver
Disease control Recruiting nowThis study tests whether a daily injection of tesamorelin can safely reduce liver fat in adults with metabolic fatty liver disease (MASLD). About 120 participants will receive either the drug or a placebo for 52 weeks, along with lifestyle advice. The main goal is to measure chan…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC
-
Could a low dose thyroid hormone help veterans with fatty liver disease?
Disease control Recruiting nowThis study tests whether a low dose of thyroid hormone (Synthroid) can help Veterans with NASH, a serious liver condition that can lead to liver failure or cancer. About 128 overweight or obese Veterans with NASH will receive either the hormone or a placebo daily for 52 weeks. Th…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Hidden liver danger in HIV patients: new screening study launches
Knowledge-focused Recruiting nowThis study aims to screen 2,000 HIV-positive individuals for metabolic fatty liver disease using a non-invasive ultrasound technique called transient elastography. The goal is to detect liver fat and scarring early, especially as HIV treatments improve survival but may increase l…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 23:19 UTC
-
New study aims to catch liver failure early in NASH patients
Knowledge-focused Recruiting nowThis study follows 240 adults with NASH-related cirrhosis to find better ways to detect early signs of liver failure, such as internal bleeding, fluid buildup, or confusion. Researchers will track health records and exams over time to improve monitoring. The goal is to understand…
Matched conditions: NONALCOHOLIC STEATOHEPATITIS
Sponsor: Virginia Commonwealth University • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC